Amgen Inc. vs Merck & Company, Inc. — Stock Comparison
Q·Score Breakdown
7.2
Buy
Overall
7.3
Buy
Quality
Health
Growth
Valuation
Sentiment
AMGN
High-quality business with 106% return on equity and 21% profit margins.
⚠ high leverage at 6.4× debt-to-equity.
MRK
High-quality business with 37% return on equity and 28% profit margins.
⚠ earnings contracting 19% year-over-year.
Analyst Consensus
HOLD
Target $352.73 (+1.1%)
30 analysts
BUY
Target $129.74 (+17.3%)
27 analysts
Fundamentals
AMGN
MRK
24.5×
Trailing P/E
15.2×
14.9×
Forward P/E
11.4×
21.0%
Profit Margin
28.1%
70.8%
Gross Margin
77.2%
106.1%
ROE
36.9%
8.6%
Revenue Growth
5.0%
112.1%
Earnings Growth
-19.3%
0.47
Beta
0.28
—
Price / Book
—
$188.2B
Market Cap
$273.2B
$261 – $391
52-Week Range
$73 – $125
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.